Therefore, the aim of the present study was to determine whether phyllodulcin could be beneficial for hyperglycemia and dyslipidemia by activating fat browning-related genes of subcutaneous fat and regulating BDNF signaling in the hypothalamus in a mouse model of high-fat diet (HFD)-induced obesity. This evidence concerns the gene BDNF and obesity disorder.